Biblio
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol. 2024;15:1366197.
Targeting Cervical Cancer Stem Cells by Phytochemicals. Curr Med Chem. 2024.
. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression. Heliyon. 2024;10(5):e27150.
. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2024:101396.
. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. Eur J Med Res. 2024;29(1):224.
. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells. Int J Oncol. 2024;64(4).
. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.
. Targeting myostatin using quercetin as a media supplement to improve myogenesis for cultured meat production: An and study. Curr Res Food Sci. 2024;8:100678.
. Targeting nuclear receptor corepressors for reversible male contraception. Proc Natl Acad Sci U S A. 2024;121(9):e2320129121.
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024.
Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis. ACS Nano. 2024.
Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells. Glycobiology. 2024.
. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions. Recent Pat Anticancer Drug Discov. 2024.
. Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy. Int Immunopharmacol. 2024;131:111876.
. Targeting TNF/IL-17/MAPK pathway in h leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842. Haematologica. 2024.
. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells. Pharmacol Res. 2024:107204.
Targeting Wnt signaling for improved glioma immunotherapy. Front Immunol. 2024;15:1342625.
Taurine induces hormesis in multiple biological models: May have transformative implications for overall societal health. Chem Biol Interact. 2024:110930.
. Taxonomic implications of normal and abnormal stomatal complexes in Indigofera L. (Indigofereae, Faboideae, Fabaceae). Protoplasma. 2024.
. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. Int J Hematol. 2024.
Tbl1 promotes Wnt/β-catenin signaling-induced degradation of the Tcf7l1 protein in mouse ESCs. J Cell Sci. 2024.
. TBX3 reciprocally controls key trophoblast lineage decisions in villi during human placenta development in the first trimester. Int J Biol Macromol. 2024:130220.
.